Objective: to assess the perioperative and postoperative results of transanal total mesorectal excision, as well as the quality of the specimens obtained by this technique. Methods: we conducted a prospective, descriptive study in consecutive patients with rectal adenocarcinoma located up to 10cm from the anal verge, without distant metastasis, subjected or not to neoadjuvant chemoradiotherapy. We evaluated the presence of technical difficulties, conversion to open abdominal route, surgical time and intra and postoperative complications. Through histopathological analysis, we assessed the quality of the mesorectum, involvement of the proximal and distal margins and positivity of the circumferential, classifying quality of the mesorectum as complete, partially complete or incomplete resection. Results: between December 2016 and May 2019, 41 patients underwent transanal total mesorectal excision, of which 75% were classified as clinical stage III, 13% clinical stage II and 12% clinical stage I. The average distance between the anal verge and the lower border of the tumor was 6.2cm. Forty percent of the tumors were in the anterior rectal wall and 17% were circumferential. The average operative time was 189 minutes. The average hospital stay was 4.6 days. There were no in-hospital deaths. Eighty-two percent of the specimens were classified as complete resection. Conclusion: transanal total mesorectal excision demonstrates adequate specimen quality and surgical margins, being associated with lower rates of perioperative complications, acceptable surgical time and short hospitalization.
INTRODUCTION
R ectal adenocarcinoma is classified as one up to 15cm from the anal verge, accounting for about 30% of all colorectal cancers. Surgical rectum anterior resection with total mesorectal excision (TME), associated or not with neoadjuvant chemoradiotherapy, is the curative approach in most cases. TME is considered the gold standard surgical treatment for rectal adenocarcinoma, and the most important factor for disease recurrence is the compromise of the circumferential margin 1, 2 .
The importance of surgical radicality in the treatment of rectal cancer has been demonstrated countless times since the initial publications by Heald et al. 3, 4 . Since then, a significant reduction in local disease recurrence has been observed.
Many studies suggest that the quality of the mesorectum obtained through TME may be a determinant prognostic factor [3] [4] [5] [6] . Over the years, the TME has migrated from the traditional laparotomic technique to the laparoscopic one, adding to the procedure the benefits of this access route 7 .
Laparoscopy provides better anatomical visualization of the pelvic cavity, facilitating the mobilization of the rectum. However, this access route has laparotomic conversion rates between 10% and 30% [7] [8] [9] .
Such conversions are mainly associated with the presence of large tumors and narrow pelvis male patients, which hampers distal tumor dissection.
The surgical technique of transanal total mesorectal excision (TaTME) was developed in order to improve the quality of the TME procedure for patients with middle and lower rectal cancer.
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Transanal total mesorectal excision combined with laparoscopic dissection: perioperative results and assessment of the mesorectal quality.
In TaTME, the distal pelvic portion of the mesorectum is approached through the anus with the aid of an endoscopic platform for natural orifice transluminal endoscopic surgery (NOTES). This technique was initially described as a procedure performed by transanal direct vision 10 , and later using a transanal endoscopic microsurgery device (TEO, STORZ®) 11 .
Over the years, after the initial publications, numerous other cases have been reported around the world [12] [13] [14] [15] [16] [17] .
In theory, TaTME facilitates mesorectal dissection, reducing the need for definitive colostomy and conversion to laparotomy. In addition, TaTME aims to increase indices of complete mesorectal resection, better determination of the distal margin, and lower rates of circumferential margin involvement compared with abdominal TME 16 . This "bottom to top" procedure potentially generates a new surgical approach option, especially in cases with very low tumors, obese patients and narrow pelvises 16 .
This study aimed to evaluate the perioperative and postoperative (in-hospital) results related to TaTME, as well as the quality of the specimens obtained by TaTME by histologically analyzing the quality of the mesorectum, involvement of the proximal and distal margins, and positivity of the circumferential margin.
METHODS
We conducted a prospective, descriptive study of consecutive patients, with rectal adenocarcinoma located up to 10cm from the anal verge, without distant metastasis, submitted or not to neoadjuvant chemoradiotherapy. We excluded from the study patients with distant metastases with indication for endoanal tumor resection that had direct invasion of other organs or of the levator ani muscle.
The patients included in the study, who had agreed to participate in the study, did so by signing a specific informed consent term. This work was The distal margin was determined by the distance between the lower edge of the tumor and the rectal resection edge, and was considered compromised when less than 5mm.
The circumferential margin was classified as positive when less than 1mm.
In the patients selected for this study, we The average distance between the anal border and the tumor lower edge was 6.2cm (3-8.8) . The average tumor size assessed by pre-neoadjuvant therapy MRI was 5cm (2-12); 16% of patients had mesorectal fascia involvement; 40% of the tumors were in the anterior rectal wall, 25% in the posterior rectal wall, 18% in the lateral rectal walls, and 17% were circumferential ( Table 2) . (Table 3) . 
RESULTS
Between
DISCUSSION
The great evolution of surgery for rectal cancer was undoubtedly due to the concept of total mesorectal excision with negative circumferential margin, instituted by Richard Heald, in the We opted for the use of a disposable flexible platform (Gelpoint®/Applaed Medical) because we believe that it offers a better field of work for transanal surgery and allows the use of the same material used in the laparoscopic surgery time, including the 10mm, 30 o scope.
Our strategy was to initiate by the laparoscopic time and then to perform the transanal time because we were in a single team, which facilitated the following logistics: 1) abdominal dissection time; As TaTME is still a subject of studies and 
